64996 Federal Register / Vol. 77, No. 206 / Wednesday, October 24, 2012 / Notices 

10Considering that sales for ‘‘electronic shopping 

and mail-order houses’’ grew from $80 billion in 

1998 to $235.0 billion in 2009 (according to Table 

1055 in the 2012 Statistical Abstracts; found on 

12s1055–1.xls available at http://www.census.gov/ 

compendia/statab/cats/wholesale_retail_trade/ 

online_retail_sales.html), staff estimates the annual 

mail or telephone sales to consumers in the threeyear period for which OMB clearance is sought will 

average $305 billion. Thus, the projected average 

labor cost for MTOR compliance by existing and 

new businesses for that period would amount to 

0.01% of sales. 

workers in sales and related occupations 

was $18.04/hr. The bulk of the burden 

of complying with the MTOR is borne 

by clerical personnel along with 

assistance from sales personnel. Staff 

believes that the mean hourly income 

for workers in sales and related 

occupations is an appropriate measure 

of a direct marketer’s average labor cost 

to comply with the Rule. Thus, the total 

annual labor cost to new and 

established businesses for MTOR 

compliance during the three-year period 

for which OMB approval is sought 

would be approximately $31,830,000 

(1,764,390 hours × $18.04/hr.), rounded 

to the nearest thousand. Relative to 

direct industry sales, this total is 

negligible.10

Estimated annual non-labor cost 

burden: $0 or minimal. 

The applicable requirements impose 

minimal start-up costs, as businesses 

subject to the Rule generally have or 

obtain necessary equipment for other 

business purposes, i.e., inventory and 

order management, and customer 

relations. For the same reason, staff 

anticipates printing and copying costs to 

be minimal, especially given that 

telephone order merchants have 

increasingly turned to electronic 

communications to notify consumers of 

delay and to provide cancellation 

options. Staff believes that the above 

requirements necessitate ongoing, 

regular training so that covered entities 

stay current and have a clear 

understanding of federal mandates, but 

that this would be a small portion of 

and subsumed within the ordinary 

training that employees receive apart 

from that associated with the 

information collected under the Rule. 

Request for Comments 

You can file a comment online or on 

paper. Write ‘‘Mail or Telephone Order 

Merchandise Trade Regulation Rule: 

FTC File No. R511929’’ on your 

comment. Your comment—including 

your name and your state—will be 

placed on the public record of this 

proceeding, including, to the extent 

practicable, on the public Commission 

Web site, at http://www.ftc.gov/os/ 

publiccomments.shtm. As a matter of 

discretion, the Commission tries to 

remove individuals’ home contact 

information from comments before 

placing them on the Commission Web 

site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, like anyone’s Social 

Security number, date of birth, driver’s 

license number or other state 

identification number or foreign country 

equivalent, passport number, financial 

account number, or credit or debit card 

number. You are also solely responsible 

for making sure that your comment does 

not include any sensitive health 

information, like medical records or 

other individually identifiable health 

information. In addition, do not include 

any ‘‘[t]rade secret or any commercial or 

financial information which is * * * 

privileged or confidential,’’ as discussed 

in Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). In particular, do not include 

competitively sensitive information 

such as costs, sales statistics, 

inventories, formulas, patterns, devices, 

manufacturing processes, or customer 

names. 

If you want the Commission to give 

your comment confidential treatment, 

you must file it in paper form, with a 

request for confidential treatment, and 

you have to follow the procedure 

explained in FTC Rule 4.9(c), 16 CFR 

4.9(c). Your comment will be kept 

confidential only if the FTC General 

Counsel, in his or her sole discretion, 

grants your request in accordance with 

the law and the public interest. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, the Commission encourages you 

to submit your comments online. To 

make sure that the Commission 

considers your online comment, you 

must file it at https:// 

ftcpublic.commentworks.com/ftc/ 

MTORpra, by following the instructions 

on the web-based form. If this Notice 

appears at http://www.regulations.gov, 

you also may file a comment through 

that Web site. 

If you file your comment on paper, 

write ‘‘Mail or Telephone Order 

Merchandise Trade Regulation Rule: 

FTC File No. R511929’’ on your 

comment and on the envelope, and mail 

or deliver it to the following address: 

Federal Trade Commission, Office of the 

Secretary, Room H–113 (Annex J), 600 

Pennsylvania Avenue NW., Washington, 

DC 20580. If possible, submit your 

paper comment to the Commission by 

courier or overnight service. 

Visit the Commission Web site at 

http://www.ftc.gov to read this Notice. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before December 24, 2012. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

http://www.ftc.gov/ftc/privacy.htm. 

David C. Shonka, 

Acting General Counsel. 

[FR Doc. 2012–26168 Filed 10–23–12; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Ventron 

Corporation, in Beverly, Massachusetts, 

as an addition to the Special Exposure 

Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. On 

October 12, 2012, the Secretary of HHS 

designated the following class of 

employees as an addition to the SEC: 

All Atomic Weapons Employees who 

worked for the Ventron Corporation at its 

facility in Beverly, Massachusetts, from 

November 1, 1942, through December 31, 

1948, for a number of work days aggregating 

at least 250 work days, occurring either 

solely under this employment, or in 

combination with work days within the 

parameters established for one or more other 

classes of employees included in the Special 

Exposure Cohort. 

This designation will become 

effective on November 11, 2012, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 


wreier-aviles on DSK5TPTVN1PROD with 
Federal Register / Vol. 77, No. 206 / Wednesday, October 24, 2012 / Notices 64997 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS C– 

46, Cincinnati, OH 45226, Telephone 1– 

877–222–7570. Information requests can 

also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–26172 Filed 10–23–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Childhood 

Lead Poisoning Prevention 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates 

9:00 a.m.–4:00 p.m., November 14, 2012 

8:45 a.m.–4:30 p.m., November 15, 2012 

9:15 a.m.–12:00 p.m., November 16, 

2012 

Place: CDC, Chamblee Campus, 

Building 106, 1st Floor, Conference 

Rooms 1A/B, 4770 Buford Highway, 

NE., Atlanta, Georgia 30341. 

Status 

This meeting is open to the public, 

limited only by the space available. The 

meeting room accommodates 

approximately 75 people. Opportunities 

will be provided during the meeting for 

oral comments. 

Purpose 

The Committee provides advice and 

guidance to the Secretary; the Assistant 

Secretary for Health; and the Director, 

CDC, regarding new scientific 

knowledge and technological 

developments and their practical 

implications for childhood lead 

poisoning prevention efforts. The 

committee also reviews and reports 

regularly on childhood lead poisoning 

prevention practices and recommends 

improvements in national childhood 

lead poisoning prevention efforts. 

Matters To Be Discussed 

Agenda items will include the 

following: Childhood Lead Poisoning 

Prevention Update—Status of our 35 

Programs; evaluation of services for 

children in Chicago; scientific program 

presentation costs and benefits of smoke 

free policies in public housing; 

Laboratory Workgroup updates; 

Educational Intervention Workgroup 

presentation; Agency updates and 

Response to ACCLPP 

Recommendations; Federal agency 

updates; HUD Guidelines (Second 

Edition); Lead-based paint/hazards 

standard review; Spot Test Kit update 

and international work. 

Agenda items are subject to change as 

priorities dictate. 

Supplemental Information: The 

public comment period is scheduled on 

Wednesday, November 14, 2012, from 

3:45 p.m.–4:00 p.m.; on Thursday, 

November 15, 2012, from 4:15 p.m.–4:30 

p.m.; and on Friday, November 16, 

2012, from 11:45 a.m.–12:00 p.m. 

Contact Person for More Information 

Sandra Malcom, Committee 

Management Specialist, NCEH/ATSDR, 

CDC, 4770 Buford Highway, Mail Stop 

F–61, Chamblee, Georgia 30345, 

Telephone: (770) 488–0575, Fax: (770) 

488–3377, Email: smalcom@cdc.gov. 

The deadline for notification of 

attendance is November 9, 2012. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 17, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–26274 Filed 10–23–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3275–N] 

Medicare Program; Meeting of the 

Medicare Evidence Development and 

Coverage Advisory Committee— 

January 30, 2013 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a 

public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) will be held on 

Wednesday, January 30, 2013. The 

Committee generally provides advice 

and recommendations concerning the 

adequacy of scientific evidence needed 

to determine whether certain medical 

items and services can be covered under 

the Medicare statute. This meeting will 

focus on beta amyloid positron emission 

tomography in dementia and 

neurodegenerative disease. This meeting 

is open to the public in accordance with 

the Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

January 30, 2013 from 7:30 a.m. until 

4:30 p.m., Eastern Standard Time (EST). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the address specified in the 

ADDRESSES section of this notice by 5 

p.m., EST, Monday, December 17, 2012. 

Once submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation is 5:00 

p.m., EST on Monday, December 17, 

2012. Speakers may register by phone or 

via email by contacting the person listed 

in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Presentation materials must be received 

at the address specified in the 

ADDRESSES section of this notice. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.asp?strOrder

By=1&type=3 or by phone by contacting 

the person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by 5 p.m. EST, Wednesday, 

January 23, 2013. 

We will be broadcasting the meeting 

live via Webcast at http://www.cms.gov/ 

live/. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Executive Secretary 

as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than 5:00 p.m., EST 

Friday, January 11, 2013. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via 


wreier-aviles on DSK5TPTVN1PROD with